Why the study?
Does modulation of nitric oxide with L-NMMA or L-arginine affect cardiac contractility and myocardial oxygen consumption in anesthetized dogs?
Does modulation of nitric oxide with L-NMMA or L-arginine affect cardiac contractility and myocardial oxygen consumption in anesthetized dogs?
Answers are grounded in this paper and cite their sources.
Endogenous nitric oxide spares myocardial oxygen consumption by reducing oxygen use in excitation-contraction coupling and attenuates cardiac contractility without altering contractile efficiency.
Nitric oxide (NO) affects myocardial contractility and myocardial oxygen consumption (MVO2) in vitro. In alpha-chloralose-anesthetized dogs instrumented for the measurements of left ventricular (LV) pressure, LV volume using a conductance catheter, coronary blood flow, and coronary venous oxygen saturation (ScvO2) using a fiber-optic catheter, LV end-systolic pressure-volume relationships (ESPVR) and the relationship between MVO2 and LV pressure-volume area (PVA) were analyzed before and after intravenous infusions of the NO synthase inhibitor NG-monomethyl-L-arginine acetate (L-NMMA; 5 mg/kg, 8 dogs) and the NO substrate L-arginine (600 mg/kg, 7 dogs). L-NMMA increased the slope of the ESPVR (Emax) (P < 0.05) without changing contractile efficiency indicated by the inverse of the slope of the MVO2-PVA line. L-NMMA also increased unloaded MVO2, indicated by the y-axis intercept of the MVO2-PVA line (P < 0.05). In contrast, L-arginine decreased Emax (P < 0.05) while decreasing MVO2 (P < 0.05), and without changing contractile efficiency. The basal oxygen metabolism was not affected by L-NMMA and L-arginine. These data imply that endogenous NO spares MVO2 by reducing oxygen use in excitation-contraction coupling and attenuates cardiac contractility without changing contractile efficiency.
No takes yet. Share an insight, caveat, or question.
Suto et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: